# The Purpose of This Study is to Assess Clinical Efficacy and Safety of Berovenal® Intended to Promote Treatment and to Expedite Chronic Diabetic Foot Ulcer Healing

> **NCT06584617** · NA · RECRUITING · sponsor: **VULM s.r.o.** · enrollment: 66 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DEVICE:** Berovenal®
- **DEVICE:** NU-GEL Hydrogel with Alginate

## Key facts

- **NCT ID:** NCT06584617
- **Lead sponsor:** VULM s.r.o.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-17
- **Primary completion:** 2025-03
- **Final completion:** 2025-12
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2024-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06584617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06584617, "The Purpose of This Study is to Assess Clinical Efficacy and Safety of Berovenal® Intended to Promote Treatment and to Expedite Chronic Diabetic Foot Ulcer Healing". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06584617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*